tiprankstipranks
Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR
US Market

Citius Pharmaceuticals (CTXR) Income Statement

Compare
1,676 Followers

Citius Pharmaceuticals Income Statement

Last quarter (Q4 2024), Citius Pharmaceuticals's total revenue was $155.93K, an increase of Infinity% from the same quarter last year. In Q4, Citius Pharmaceuticals's net income was $-10.79M. See Citius Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -194.32K$ -179.68K$ -164.87K$ -152.36K
Operating Expenses
$ 42.00M$ 36.73M$ 33.32M$ 23.53M$ 17.71M
Depreciation and Amortization
$ 0.00$ 194.32K$ 179.68K$ 164.87K$ 152.36K
EBITDA
$ 0.00$ -36.73M$ -32.88M$ -22.88M$ -17.38M
Operating Income
$ 0.00$ -36.73M$ -33.32M$ -23.53M$ -17.71M
Other Income/Expenses
$ 0.00$ 4.77M$ 251.40K$ 477.46K$ 162.60K
Pretax Income
$ -38.85M$ -31.97M$ -33.06M$ -23.05M$ -17.55M
Net Income
$ -39.43M$ -32.54M$ -33.64M$ -23.13M$ -17.67M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.23$ -0.23$ -0.23$ -0.21$ -0.45
Diluted EPS
$ -0.23$ -0.22$ -0.23$ -0.21$ -0.45
Weighted Average Shares Outstanding
173.86M 146.13M 146.08M 108.60M 39.17M
Weighted Average Shares Outstanding (Diluted)
173.86M 151.29M 146.08M 108.60M 39.17M
Currency in USD

Citius Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis